Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
38 Cards in this Set
- Front
- Back
modified-release dosage form is:
|
a dosage form having the time course and/or location of the drug release chosen to accomplish therapeutic or convenience objectives not offered by conventional dosage forms
|
|
conventional dosage forms:
|
fast release of the drug at the site of administration
|
|
various types of modified- release products:
|
mainly oral, but also transdermal, intramuscular, subcutaneous
|
|
(modified- released products)
extended-release dosage form: |
- the release starts immediately, but is slow
- results in at least two-fold reduction in the dosing frequency |
|
(modified- released products)
delayed-release dosage form: |
- releases a discrete portion of the dose at a later time, although one portion can be released immediately
|
|
(modified- released products)
targeted-release dosage form: |
- releases drug at or near the intended physiologic site of action
|
|
(extended- released dosage forms)
prolonged-release dosage form |
- releases the drug slowly
- provides a drug continuous supply over an extended period - oral dosing + all other categories |
|
(extended- released dosage forms)
sustained- release dosage form |
- delivers an initial (loading) dose immediately
- the loading dose is followed by a slow and constant release |
|
(delayed-release dosage forms)
enteric-coated tablet |
- the enteric coating is stable in stomach
- it will dissolve in the higher pH of small intestine - used for drugs irritating stomach and to increase stability of hydrolyzing drugs |
|
(delayed-release dosage forms)
repeat-release tablet |
- the first dose is released immediately
- the second dose is released later - saves one administration |
|
(targeted-release dosage form)
first-order targeting |
drug is delivered to the capillary bed of the site of action
|
|
(targeted-release dosage form)
second-order targeting |
drug is delivered to the surroundings of a special cell type (eg tumor cells)
|
|
(targeted-release dosage form)
third-order targeting |
drug is delivered to intracellular space of the target cells
|
|
pharmacokinetics of modified release products: drug release
release of the drug can be: |
instantaneous (delayed-release)
zero-order process (extended release products, mostly non-oral) approximately first order process- oral extended-release products |
|
If the release is not immediate, one more compartment is added to the compartment model:
|
dosage-form compartment
|
|
pharmacokinetics of extended-release products I
designed for : |
zero- order release (ideal case)
|
|
for oral products, zero-order kinetics frequently not achieved in vivo due to irregularities in:
|
- the stomach (food, change of pH; absorption; agitation
- small intestine (transit time too short: 4-6 hrs - large intestine (bacteria, lack of water) |
|
pharmacokinetics of extended- release products II
fast absorption eliminates what compartment? |
dosing compartment
|
|
pharmacokinetics of extended- release products II
fast plasma/tissue equilibriation eliminates what compartment (s)? |
tissue compartment and deep tissue compartment
|
|
Used compartment models
|
see pg 2 slide 5
|
|
pharmacokinetics of extended- release products II
for fast absorption and fast plasma/tissue distribution, both two-compartment models will be used in: |
a similar way as previously for slow absorption
|
|
pharmacokinetics of extended- release products II
the rate constant of absorption will be substituted by: |
the rate constant of drug release
|
|
pharmacokinetics of extended- release products II
there are separate descriptions for the zero-order release and the first-order release |
true
|
|
zero-order drug release: time of drug release
drug release proceeds at a constant rate until : |
the amount of the drug in the dosage form is depleted
|
|
zero-order drug release: time of drug release
effective dose is: |
Deff= Fr * D (1)
the drug amount available for release |
|
zero-order drug release: time of drug release
what is Kro? |
the rate at which the effective dose is released
|
|
zero-order drug release: time of drug release
the time of release is (equation)? |
Fr * D (2)
tr= --------------- Kro * Vd |
|
zero-order drug release: time course of plasma concentration
there are 2 phases: |
release phase
elimination phase |
|
zero-order drug release: time course of plasma concentration
release phase: |
cp --> increasing
cp(t)= Kro/ke * (1-e^-ke*t) |
|
zero-order drug release: time course of plasma concentration
the elimination phase: t=tr |
cp --> decreasing
cp(t)= cp(tr) * e^-ke*t |
|
zero-order drug release: time course of plasma concentration
the elimination phase: starts at time of administration: |
cp--> decreasing
cp(t)= cp(tr) * e^-ke * (t-tr) |
|
zero-order release: plasma concentration- time profile II
the rate at which the (ss) is achieved depends on the : |
elimination rate constant, ke
|
|
zero-order release: plasma concentration- time profile II
the duration (length) of the plateau level depends on: |
the dose, D
|
|
zero-order release: plasma concentration- time profile II
during the plateau level, in plasma- rate of release = |
rate of elimination
|
|
at the plateau level, the two rates are equal
equation: |
Kro= ke * cp(ss)
|
|
first order drug release: models and descriptions:
|
kr
dosage form compartment ----> central compartment----> ke |
|
first-order drug release: time course of the plasma concentration
fast absorption and fast plasma/tissue equilibrium is assumed |
true
|
|
what is peak time?
|
the time when the maximum plasma concentration is achieved
|